RAPS: New FDA Guidance Calls for Increased Emphasis on Centralized Trial Monitoring A new guidance document released by the US Food and Drug Administration on 6 August 2013 calls on sponsors to develop centralized risk-based monitoring strategies for clinical trials involving medical ...